Furthermore, carvacrol pre‐treatment down‐regulated protein expression of inducible nitric oxide synthase (iNOS), NF‐κB and COX‐2 causing a decrease in the number of cancer marker cells and restoring histopathological changes made to the lung tissues.40 This evidence concerns the gene PTGS2 and cancer.